why choose us

Clinical Trials Search

Showing 13,490 of 132,963 result(s)
Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR®

Status: Completed

Condition: Asthma

Interventions:

CHF 5993 BDP;FF;GB 200;6;12.5 µg pMDI with HFA 134a propellant (fixed combination of BDP [200 ?g], FF [6 ?g] and GB [12.5 ?g] v

Date: 2023-04-14

Safety and Efficacy of Voxzogo for Growth Deficits in MPS IVA and VI

Status: Completed

Condition: MPS IVA

Interventions: Vosoritide will be given via a once daily subcutaneous injection at a dose of 15 ug;kg;day, at approximately the same time each day when fea

Date: 2023-04-14

Strong Hearts: A Remote, App-Enabled, Exercise Program for Patients With Congenital Heart Disease (Strong Hearts App)

Status: NOT_YET_RECRUITING

Condition: Congenital Heart Disease

Interventions: The participant will either begin at the easiest variation of each strength exercise (level A), or will be placed at a specific level for each strengt

Date: 2023-04-14

A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection

Status: Completed

Condition: Clostridium Difficile Infection Recurrence

Interventions: RBX2660 should be administered to the right side of the colon (i.e., between the ileocecal valve and the hepatic flexure of the colon).

Date: 2023-04-14

Role of Ashwagandha Extract (Capsule KSM-66 300 mg) in Improving Sexual Health in Healthy Men

Status: Completed

Condition: Sexual Health

Interventions: KSM-66 Ashwagandha is the active ingredient in Waithania somifera, a medicinal plant in Indian medicine.
Ashwagandha is known as an adaptogen, an

Date: 2023-04-14

The Role of Licensing in Early Care and Education: Licensing Administrators

Status: COMPLETED

Condition: Licensing Administrator Perceptions of the Licensing System

Interventions:

Date: 2023-04-14

DIGITAL Biomarker: Blood Based Biomarkers in the Primary Care Setting for Alzheimer's Disease

Status: COMPLETED

Condition: Mild Cognitive Impairment

Interventions: Measure risk for amyloid plaques in the brain and will include a test for certain genetic variants (specifically, ApoE proteins in the blood revealing

Date: 2023-04-14

Outreach Core Activities

Status: Completed

Condition: Cancer Education

Interventions: The Spanish version of Cancer 101 consists of several modules that address cancer control and prevention, risk factors, early detection and screening

Date: 2023-04-14

Emergency Department Re-evaluation Software Pilot Study

Status: COMPLETED

Condition: Emergency Department Waiting Room Congestion

Interventions: Patients utilize software after being screened, but prior to being re-evaluated by physician

Date: 2023-04-14

Comparison of Three Methods of PEEP Titration During One Lung Ventilation in Prone Position

Status: COMPLETED

Condition: One Lung Ventilation

Interventions: Constant PEEP of 5 cm H2O will be applied and maintained throughout one-lung ventilation.

Date: 2023-04-14